[LRMR] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[LRMR] Larimar Therapeutics, Inc.
Announcement Date
10-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- 22.09%
Quarter Report
LRMR's Result
LRMR's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -42,482 -23,132 -62,968 -52,928 -58,178 -74,286 -36,570 2.52%
Tax -155 -94 -1,600 -900 -300 -946 0 -
NP -42,327 -23,132 -61,368 -52,028 -57,878 -74,286 -36,570 2.46%
Tax Rate - - - - - - - -
Total Cost 42,327 23,132 61,368 52,028 57,878 74,286 36,570 2.46%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -3.56 -2.51 -22.85 -22.76 -25.44 -33.32 -15.14 -21.41%
EPS Diluted -3.56 -2.51 -22.85 -22.76 -25.44 -33.32 -15.14 -21.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.